Corcept Therapeutics IncCORT
What Corcept Therapeutics Inc does.
We are a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol.
Cortisol plays a significant role in the body’s response to stress and is essential for survival. Cortisol influences metabolism and the immune system and contributes to emotional stability. Cortisol levels follow a diurnal rhythm that is essential to health, peaking upon awakening and decreasing during the day. Insufficient cortisol activity may lead to dehydration, hypotension, shock, fatigue and hypoglycemia. Excessive cortisol activity, known as hypercortisolism, may lead to hypertension, diabetes, impaired glucose tolerance, obesity, fatty liver disease, depressed mood, psychosis, wasting of the arms and legs, edema, fatigue, insomnia and other problems.
Cortisol reduces a patient’s immune response to oncogenesis, shields certain cancer cells from the apoptotic effects of chemotherapy and facilitates the growth of others. Pre-clinical and clinical data indicate that modulating cortisol activity may improve outcomes in patients with fatty liver disease and metabolic dysfunction-associated steatohepatitis (“MASH”), which are precursors of liver fibrosis and cirrhosis. Pre-clinical and clinical data also suggest that modulating cortisol activity may lead to treatments for patients with amyotrophic lateral sclerosis (“ALS”).
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $353.9M | $366.0M | $401.9M | $482.4M | $675.0M | $761.4M |
| Net income | $106.0M | $112.5M | $101.4M | $106.1M | $141.2M | $99.7M |
| Free cash flow | $150.7M | $167.4M | $119.9M | $126.5M | $196.1M | $141.8M |
More on CORT.
- Corcept Therapeutics Inc summary
- Corcept Therapeutics Inc financial statements
- Corcept Therapeutics Inc key metrics
- Corcept Therapeutics Inc health scores and style box
- Corcept Therapeutics Inc earnings
- Corcept Therapeutics Inc dividends
- Corcept Therapeutics Inc valuation
- Corcept Therapeutics Inc ownership and insiders
- Corcept Therapeutics Inc peers
Figures from Corcept Therapeutics Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.